Bernadette Connaughton
Director/Miembro de la Junta en HALOZYME THERAPEUTICS, INC. .
Fortuna: 3 M $ al 30/04/2024
Cargos activos de Bernadette Connaughton
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director/Miembro de la Junta | 10/09/2018 | - |
| Independent Dir/Board Member | 10/09/2018 | - | |
| ZEALAND PHARMA A/S | Director/Miembro de la Junta | 04/04/2019 | - |
| Independent Dir/Board Member | 04/04/2019 | - | |
| EDITAS MEDICINE, INC. | Director/Miembro de la Junta | 26/10/2021 | - |
| Independent Dir/Board Member | 26/10/2021 | - | |
| Boys & Girls Clubs of New Jersey | Director/Miembro de la Junta | - | - |
Historial de carrera de Bernadette Connaughton
Antiguos cargos conocidos de Bernadette Connaughton.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SYNEOS HEALTH, INC. | Director/Miembro de la Junta | 12/11/2019 | 28/09/2023 |
| Independent Dir/Board Member | 12/11/2019 | 28/09/2023 | |
| VISTERRA INC | Director/Miembro de la Junta | 01/12/2015 | 01/08/2018 |
| Bristol-Myers Squibb Pharma Co. | Corporate Officer/Principal | 01/01/2004 | 01/10/2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2004 | 01/01/2017 |
Formación de Bernadette Connaughton.
| The Johns Hopkins University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 10 |
| Dinamarca | 2 |
Operativa
| Director/Board Member | 6 |
| Independent Dir/Board Member | 4 |
| Corporate Officer/Principal | 2 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
| Bristol-Myers Squibb Pharma Co. | |
| Boys & Girls Clubs of New Jersey | |
Syneos Health, Inc.
 Syneos Health, Inc. BiotechnologyHealth Technology Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
